Literature DB >> 6995504

Some considerations for the planning of total-community prevention trials--when is sample size adequate?

R F Gillum, P T Williams, E Sondik.   

Abstract

Despite the large accumulated experience of statisticians with sample-size calculations for clinical trials, little information is available on extending this methodology to total community trials, in which the units of randomization are total communities and surveillance methods are used to assess event rates. As in clinical trials, the asymptotic formula for total sample size is used. However, the assumptions underlying the usual method of computing the expected T-year even rate for the experimental group, pe, are no longer valid in total community trials: all emigrants (dropouts) from large communities cannot practically be identified or followed. Immigrants, similar to dropouts in clinical trials in that they are exposed to the treatment for only a portion of the period but are followed to the end of the study, present an additional problem. This paper presents a method for the computation of pe in total community trials, taking into account in- and out-migration as well as the determinants usually considered in clinical trials. Sample computations are presented, and general problems of design, execution and data analysis of total community prevention trials are briefly discussed.

Entities:  

Mesh:

Year:  1980        PMID: 6995504     DOI: 10.1007/bf01324196

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  8 in total

1.  A plea for a discipline of health and medical evaluation.

Authors:  M M Henderson; C L Meinert
Journal:  Int J Epidemiol       Date:  1975-03       Impact factor: 7.196

2.  Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial Group.

Authors: 
Journal:  J Chronic Dis       Date:  1977-05

3.  The North Karelia project: an attempt at community prevention of cardiovascular disease.

Authors:  P Puska
Journal:  WHO Chron       Date:  1973-02

4.  Sample izes for medical trials with special reference to long-term therapy.

Authors:  M Halperin; E Rogot; J Gurian; F Ederer
Journal:  J Chronic Dis       Date:  1968-01

5.  Selected risk factors in coronary disease. Possible intervention effects.

Authors:  J Cornfield; S Mitchell
Journal:  Arch Environ Health       Date:  1969-09

6.  Community surveillance for cardiovascular disease. Methods, problems, applications--a review.

Authors:  R F Gillum
Journal:  J Chronic Dis       Date:  1978-02

7.  The determination of sample size in treatment-control comparisons for chronic disease studies in which drop-out or non-adherence is a problem.

Authors:  M A Schork; R D Remington
Journal:  J Chronic Dis       Date:  1967-04

8.  Community education for cardiovascular health.

Authors:  J W Farquhar; N Maccoby; P D Wood; J K Alexander; H Breitrose; B W Brown; W L Haskell; A L McAlister; A J Meyer; J D Nash; M P Stern
Journal:  Lancet       Date:  1977-06-04       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.